Antiprotozoal QSAR modelling for trypanosomiasis (Chagas disease) based on thiosemicarbazone and thiazole derivatives

2018 Linares, 2006, Progresses in the field of drug design to combat tropical protozoan parasitic diseases, Curr. Med. Chem., 13, 335, 10.2174/092986706775476043 De Souza, 1984, Cell biology of Trypanosoma cruzi, Int. Rev. Cytol., 86, 197, 10.1016/S0074-7696(08)60180-1 Docampo, 2010, Biochemistry of trypanosoma cruzi, 365 Urbina, 2002, Chemotherapy of Chagas disease, Curr. Pharmaceut. Des., 8, 287, 10.2174/1381612023396177 2018, Characteristics of patients for whom benznidazole was realized through the CDC-sponsored investigational new drug program for treatment of Chagas disease – United States, 2011–2018, MMWR (Morb. Mortal. Wkly. Rep.), 67, 803, 10.15585/mmwr.mm6729a3 Cunha Almeida, 2018, Synthesis, in vitro and in vivo anti-Trypanosoma cruzi and toxicological activities of nitroaromatic Schiff bases, Biomed. Pharmacother, 108, 1703, 10.1016/j.biopha.2018.09.176 Álvarez, 2014, Optimization of antitrypanosomatid agents: identification of nonmutagenic drug candidates with in vivo activity, J. Med. Chem., 57, 3984, 10.1021/jm500018m Ud Din, 2018, Symmetrical and unsymmetrical substituted 2,5-diarylidene cyclohexanones as anti-parasitic compounds, Eur. J. Med. Chem., 155, 596, 10.1016/j.ejmech.2018.06.031 Scarim, 2018, Current advances in drug discovery for Chagas disease, Eur. J. Med. Chem., 155, 824, 10.1016/j.ejmech.2018.06.040 De Oliveira Cardoso, 2014, 2-Pyridyl thiazoles as novel anti-Trypanosoma cruzi agents: structural design, synthesis and pharmacological evaluation, Eur. J. Med. Chem., 86, 48, 10.1016/j.ejmech.2014.08.012 Magalhaes Moreira, 2014, Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death, Eur. J. Med. Chem., 75, 467, 10.1016/j.ejmech.2014.02.001 Pontes, 2015, Synthesis and structure–activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain, Eur. J. Med. Chem., 101, 818, 10.1016/j.ejmech.2015.06.048 De Moraes Gomes, 2016, Phthalimido-thiazoles as building blocks and their effects on the growth and morphology of Trypanosoma cruzi, Eur. J. Med. Chem., 111, 46, 10.1016/j.ejmech.2016.01.010 De Moraes Gomes, 2016, New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi, Eur. J. Med. Chem., 121, 387, 10.1016/j.ejmech.2016.05.050 Da Silva, 2017, Design and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death, Eur. J. Med. Chem., 130, 39, 10.1016/j.ejmech.2017.02.026 De Oliveira Filho, 2017, Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi, Eur. J. Med. Chem., 141, 346, 10.1016/j.ejmech.2017.09.047 Rojas, 2015, Quantitative structure–property relationship analysis for the retention index of fragrance-like compounds on a polar stationary phase, J. Chromatogr. A, 1422, 277, 10.1016/j.chroma.2015.10.028 Duchowicz, 2005, A new search algorithm for QSPR/QSAR theories: normal boiling points of some organic molecules, Chem. Phys. Lett., 412, 376, 10.1016/j.cplett.2005.07.016 2014 Chun Wei, 2014 Mercader, 2010, Replacement method and enhanced replacement method versus the genetic algorithm approach for the selection of molecular descriptors in QSPR/QSAR theories, J. Chem. Inf. Model., 50, 1542, 10.1021/ci100103r Golbraikh, 2002, Beware of q2!, J. Mol. Graph. Model., 20, 269, 10.1016/S1093-3263(01)00123-1 Rücker, 2007, y-Randomization and its Variants in QSPR/QSAR, J. Chem. Inf. Model., 47, 2345, 10.1021/ci700157b Eriksson, 2003, Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs, Environ. Health Perspect., 111, 1361, 10.1289/ehp.5758 Roy, 2015, On a simple approach for determining applicability domain of QSAR models, Chemometr. Intell. Lab. Syst., 145, 22, 10.1016/j.chemolab.2015.04.013 Wilson Van Voorhis, 2007, Understanding power and rules of Thumb for determining sample size, TQMP, 3, 43, 10.20982/tqmp.03.2.p043 Sawilowsky, 2009, New effect size rules of Thumb, J. Mod. Appl. Stat. Methods, 8, 597, 10.22237/jmasm/1257035100 Amin, 2016, Modelling the cytotoxic activity of pyrazolo-triazole hybrids using descriptors calculated from the open source tool “PaDEL-descriptor”, J Taibah Univ Sci, 10, 896, 10.1016/j.jtusci.2016.04.009 Basant, 2018, Multi-target QSPR modeling for simultaneous prediction of multiple gas-phase kinetic rate constants of diverse chemicals, Atmos. Environ., 177, 166, 10.1016/j.atmosenv.2017.11.028 Todeschini, 2009, vols. 27–37, 714 Channar, 2017, Design and synthesis of 2,6-di(substituted phenyl)thiazolo[3,2-b]-1,2,4-triazoles as α-glucosidase and α-amylase inhibitors, co-relative Pharmacokinetics and 3D QSAR and risk analysis, Biomed Pharmacother, 94, 499, 10.1016/j.biopha.2017.07.139 Liang, 2011, Prediction of the aquatic toxicity of phenols to Tetrahymena pyriformis from molecular descriptors, Int. J. Environ., 5, 923 Gupta Manish, 2005, Quantitative structure – activity relationship to predict differential inhibition of aldose reductase by flavonoid compounds, Bioorg. Med. Chem., 13, 3269, 10.1016/j.bmc.2005.02.038 Adeniji, 2018, In silico study for investigating and predicting the activities of 1,2,4-triazole derivaties as potent anti-tubercular agents, J Eng Exact Sc, 4, 246, 10.18540/jcecvl4iss2pp0246-0254 Klekota, 2008, Chemical substructures that enrich for biological activity, Bioinformatics, 24, 2518, 10.1093/bioinformatics/btn479 Saíz-Urra, 2007, 2D-autocorrelation descriptors for predicting cytotoxicity of naphthoquinone ester derivatives against oral human epidermoid carcinoma, Bioorg. Med. Chem., 15, 3565, 10.1016/j.bmc.2007.02.032 Roy, 2013, Some case studies on application of ‘‘rm 2 ’’ metrics for judging quality of quantitative structure–activity relationship predictions: emphasis on scaling of response data, J. Comput. Chem., 34, 1071, 10.1002/jcc.23231 Gajo, 2016, Quantitative structure-activity relationship studies for potential rho-associated protein kinase inhibitors, J. Chem., 1